Comment on ERS/ESRS statement on adaptive servo-ventilation for treatment of central sleep apnoea
Abstract
Extract The European Respiratory Society and European Sleep Research Society statement on the treatment of central sleep apnoea (CSA) with adaptive servo-ventilation (ASV) provides a thorough and timely update on this important topic [1]. However, the statement conflates all forms of ASV as if these represent a generic intervention with uniform properties and treatment outcomes in patients with heart failure and reduced ejection fraction (HFrEF), when randomised trials indicate otherwise. Furthermore, it asserts, without corroborating data, that the ADVENT-HF trial was “statistically underpowered, particularly, to definitively address safety issues”.
Fields of Study & Subjects
Obstructive Sleep Apnea Research
Neuroscience of respiration and sleep
Respiratory Support and Mechanisms
Publication details
- Journal / source
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Volume
- 67
- Issue
- 3
- Pages
- 2502273–2502273
- Publication date
- 1 March 2026
- Language
- EN